Measuring the cost-effectiveness of treating rectovaginal and vesicovaginal fistulas: A multicenter global study by the Fistula Foundation

被引:1
|
作者
Rajagopal, Keerthana [1 ,2 ]
Pollaczek, Lindsey [1 ]
Chu, Jesse [1 ]
Mann, Hannah [1 ]
机构
[1] Fistula Fdn, San Jose, CA USA
[2] Fistula Fdn, 1700 The Alameda 300, San Jose, CA 95126 USA
关键词
cost-effectiveness; disability-adjusted life-years; rectovaginal fistula; resource allocation; vesicovaginal fistula; OBSTETRIC FISTULA;
D O I
10.1002/ijgo.15502
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
ObjectiveSurgery for obstetric fistula is a highly effective treatment to restore continence and improve quality of life. However, a lack of data on the cost-effectiveness of this procedure limits prioritization of this essential treatment. This study measures the effectiveness of fistula surgeries using disability-adjusted life years (DALYs) averted.MethodsIn 2021 and 2022, the Fistula Foundation funded 20 179 fistula surgeries and related procedures at 143 hospitals among 27 countries. We calculated DALYs averted specifically for vesicovaginal fistula and rectovaginal fistula procedure types (n = 13 235 surgeries) by using disability weights from the 2019 Global Burden of Disease study. We based cost calculations on direct treatment expenses, including medical supplies, health provider fees, and preoperative and postoperative care. We measured effectiveness using data on the risk of permanent disability, country-specific average life spans, and treatment outcomes.ResultsThe total treatment cost was $7.6 million, and a total of 131 433 DALYs were averted. Thus, the cost per DALY averted-the cost to restore 1 year of healthy life-was $58. For this analysis, we took a cautious approach and weighted only surgeries that resulted in a closed fistula with restored continence. We calculated DALYs averted by country. Limitations of the study include data entry errors inherent in patient logs and lack of long-term outcomes.ConclusionThe current study demonstrates that obstetric fistula surgery, along with having a significant positive impact on maternal health outcomes, is highly cost-effective in comparison with other interventions. The study therefore highlights the benefits of prioritizing fistula treatment as part of the global agenda for maternal health care. Obstetric fistula treatment is highly cost-effective. The current study highlights the benefits of prioritizing fistula treatment as part of the global agenda for maternal health care.
引用
收藏
页码:480 / 486
页数:7
相关论文
共 50 条
  • [41] Cost-effectiveness of treating by simvastatin 40 mg/day high vascular risk patients: An economic evaluation based on the heart protection study
    Fagnani, F
    Lafuma, A
    Souchet, T
    VALUE IN HEALTH, 2003, 6 (03) : 320 - 320
  • [42] Cost-effectiveness of intensive atorvastatin therapy in secondary cardiovascular prevention in the United Kingdom, Spain, and Germany, based on the Treating to New Targets study
    Douglas C. A. Taylor
    Ankur Pandya
    David Thompson
    Paula Chu
    Jennifer Graff
    James Shepherd
    Nanette Wenger
    Heiner Greten
    Rafael Carmena
    Michael Drummond
    Milton C. Weinstein
    The European Journal of Health Economics, 2009, 10 : 255 - 265
  • [43] Cost-effectiveness of diagnosis and treatment of early gestational diabetes mellitus: economic evaluation of the TOBOGM study, an international multicenter randomized controlled trial
    Haque, Mohammad M.
    Tannous, W. Kathy
    Herman, William H.
    Immanuel, Jincy
    Hague, William M.
    Teede, Helena
    Enticott, Joanne
    Cheung, N. Wah
    Hibbert, Emily
    Nolan, Christopher J.
    Peek, Michael J.
    Wong, Vincent W.
    Flack, Jeff R.
    Mclean, Mark
    Sweeting, Arianne
    Gianatti, Emily
    Kautzky-Willer, Alexandra
    Harreiter, Jurgen
    Mohan, Viswanathan
    Backman, Helena
    Simmons, David
    ECLINICALMEDICINE, 2024, 71
  • [44] Cost-effectiveness analysis of magnetic resonance imaging-conditional pacemaker implantation: Insights from a multicenter study and implications in the current era
    Mar, Philip L.
    Chen, Guanhua
    Gandhi, Gaurang
    Tang, Zheng-Zheng
    Leiserowitz, Amy
    Tripuraneni, Ajay
    Kreps, Eric
    Botting, Luke
    Lakkireddy, Dhanunjaya
    Granato, Jerome E.
    Gopinathannair, Rakesh
    HEART RHYTHM, 2018, 15 (11) : 1690 - 1697
  • [45] Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling study
    Scott, Nick
    Palmer, Anna
    Morgan, Christopher
    Lesi, Olufunmilayo
    Spearman, C. Wendy
    Sonderup, Mark
    Hellard, Margaret
    LANCET GLOBAL HEALTH, 2018, 6 (06): : E659 - E667
  • [46] Cost-effectiveness of selective neck dissection versus modified radical neck dissection for treating metastases in patients with oral cavity cancer: A modelling study
    Govers, Tim M.
    Patel, Sejal
    Takes, Robert P.
    Merkx, Thijs
    Rovers, Maroeska
    Grutters, Janneke
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (12): : 1762 - 1768
  • [47] A Multicenter, Retrospective, Matched, Comparison Study of Clinical Efficacy and Cost-Effectiveness of Caterpillar Arterial Embolization Device versus Fibered Coils in Arterial Embolization
    Sue, Megan J.
    Luong, Thanh T.
    Park, Jonathan
    Ding, Peng-Xu
    Hao, Frank
    Eghbalieh, Navid
    Lee, Edward Wolfgang
    APPLIED SCIENCES-BASEL, 2022, 12 (10):
  • [48] Clinical and Cost-Effectiveness of PSYCHOnlineTHERAPY: Study Protocol of a Multicenter Blended Outpatient Psychotherapy Cluster Randomized Controlled Trial for Patients With Depressive and Anxiety Disorders
    Baumeister, Harald
    Bauereiss, Natalie
    Zarski, Anna-Carlotta
    Braun, Lina
    Buntrock, Claudia
    Hoherz, Christian
    Idrees, Abdul Rahman
    Kraft, Robin
    Meyer, Pauline
    Nguyen, Tran Bao Dat
    Pryss, Rudiger
    Reichert, Manfred
    Sextl, Theresa
    Steinhoff, Maria
    Stenzel, Lena
    Steubl, Lena
    Terhorst, Yannik
    Titzler, Ingrid
    Ebert, David Daniel
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [49] The efficacy, safety and cost-effectiveness of hydrotalcite versus esomeprazole in on-demand therapy of NERD: A multicenter, randomized, open-label study in China
    Xiao, Ying Lian
    Nie, Yu Qiang
    Hou, Xiao Hua
    Xie, Peng Yan
    Fang, Jing Yuan
    Yuan, Yao Zong
    Zhou, Li Ya
    Zhao, Nai Qing
    Chen, Min Hu
    JOURNAL OF DIGESTIVE DISEASES, 2013, 14 (09) : 463 - 468
  • [50] Cost-Effectiveness and Cost-Utility Analyses in Thailand of Continuous Intrathecal Morphine Infusion Compared with Conventional Therapy in Cancer Pain: A 10-year Multicenter Retrospective Study
    Thepsuwan, Arpawan
    Tontisirin, Nuj
    Euasobhon, Pramote
    Pannangpetch, Patt
    Leerapan, Borwornsom
    Pattanaprateep, Oraluck
    Cohen, Steven P.
    CANADIAN JOURNAL OF PAIN-REVUE CANADIENNE DE LA DOULEUR, 2023, 7 (01):